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ABSTRACT 
 
Ocular coloboma is a common eye malformation resulting from incomplete fusion of the 
optic fissure during development. Coloboma is often associated with microphthalmia and/or 
contralateral anophthalmia. Coloboma shows extensive locus heterogeneity associated with 
causative mutations identified in genes encoding developmental transcription factors or 
components of signaling pathways. We report an ultra-rare, heterozygous frameshift 
mutation in FZD5 (p.Ala219Glufs*49) that was identified independently in two branches of a 
large family with autosomal dominant non-syndromic coloboma. FZD5 has a single coding 
exon and consequently a transcript with this frameshift variant is not a canonical substrate 
for nonsense-mediated decay. FZD5 encodes a transmembrane receptor with a conserved 
extracellular cysteine rich domain (CRD) for ligand binding. The frameshift mutation results 
in the production of a truncated protein, which retains the WNT-ligand binding domain but 
lacks the transmembrane domain. The truncated protein was secreted from cells, and 
behaved as a dominant-negative FZD5 receptor, antagonizing both canonical and non-
canonical WNT signaling. Expression of the resultant mutant protein caused coloboma and 
microphthalmia in zebrafish, and disruption of the apical junction of the retinal neural 
epithelium in mouse, mimicking that of Fz5/Fz8 compound conditional knockout mutants. 
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Our studies have revealed a conserved role of Wnt-Frizzled signaling in ocular development 
and directly implicate WNT-FZD signaling both in normal closure of the human optic fissure 
and pathogenesis of coloboma.  
 
 
INTRODUCTION 
Ocular coloboma (OC) is a developmental structural defect caused by the abnormal 
persistence of the optic fissure in post-embryonic life. In combination with microphthalmia 
(small eyes) and anophthalmia (absent eyes), OC represents a spectrum of malformations 
that account for an estimated 10% to 15% of pediatric blindness (1). Transcription factors 
and signaling pathways play crucial roles in optic cup morphogenesis and fissure closure (2, 
3). Accordingly, human genetic studies together with vertebrate models have implicated 
Bone Morphogenetic Protein (BMP) (4-7), Hedgehog (Hh) (8), Retinoic Acid (RA) (9-11) and 
Hippo (12) pathways in the pathogenesis of these ocular malformations (8, 13-15). Defects 
in components of Wnt signaling have been attributed to syndromic and non-syndromic 
ocular diseases, including Norrie disease (16, 17), osteoporosis-pseudoglioma syndrome 
(18) and familial exudative vitreoretinopathy (16, 17, 19-21), but not with abnormalities 
associated with ocular morphogenesis.    
A growing body of evidence from several vertebrate models indicates that Wnt 
signaling is indispensable in optic field development and ocular morphogenesis. In the Wnt 
pathway, non-canonical (β-catenin-independent) signaling interacts with canonical (β-
catenin-dependent) signaling to control presumptive retinal versus forebrain fates (22). Loss 
of non-canonical ligands, Wnt5 and Wnt11, causes failure of eye field segregation (22), 
whereas inactivation of β-catenin prior to optic vesicle differentiation causes anophthalmia 
(23). At later stages of development, the canonical pathway also contributes to optic cup 
morphogenesis, with overexpression of the Wnt inhibitor Dkk1 leading to abnormal lens 
formation and coloboma (24, 25). Furthermore, loss of the Secreted Frizzled Related 
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Proteins (sFRPs; known modulators of Wnt signaling) causes defects in optic cup patterning 
(26).  
The Wnt receptor Frizzled-5 (Fzd5) mediates both canonical and non-canonical 
signaling (22, 27). During eye field specification, Fzd5 is specifically expressed in 
evaginating eye precursors (28, 29). In zebrafish, Wnt11-Fzd5 signaling promotes eye field 
specification using the non-canonical pathway (22). In Xenopus, Fzd5 acting via the 
canonical pathway controls the neural potential of retinal progenitors through regulation of 
Sox2 (30). Mouse Fzd5-/- mutants display extreme optic cup invagination defects with failure 
to induce lens formation (31), whereas conditional Fzd5 mutants (Supplementary Fig.1) 
exhibit both microphthalmia and coloboma with disrupted retinal epithelial apical junctions 
(27, 32) implicating Fzd5 in mammalian ocular morphogenesis and early neurogenesis.  
Additionally, mouse knockout mutants of Lrp6, encoding Fzd co-receptor presumed to be in 
the canonical Wnt signaling pathway (33), demonstrate ocular phenotypes similar to those 
observed in the conditional Fzd5 mutants. We therefore hypothesized that mutations in 
FZD5 may be involved in the development of human congenital ocular malformations. In this 
study, we tested this hypothesis using two independent methods: an unbiased genetic 
screen, and a candidate gene approach. Both of these identified the same single novel 
frameshift mutation in FZD5 in a large, extended family in which non-syndromic OC 
segregated as an autosomal dominant disorder. Functional analysis of the mutant protein, 
using zebrafish and mouse retinal explants, strongly suggests a dominant negative effect on 
WNT signaling which is likely responsible for optic fissure closure defects. The present study 
therefore directly implicates WNT-FZD signaling in the pathogenesis of human coloboma.  
 
RESULTS 
A frameshift mutation in FZD5 causes automomal dominant coloboma  
Whole exome sequencing (WES) was performed as part of the Rare Disease component of 
UK10K (www.uk10k.org) in five members of a large family with autosomal dominant OC 
(Family 3483; Fig. 1A-C). The affected individuals IV:6, V:1, VI:2 and VI:5 shared only one 
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ultra-rare variant (not present in ExAC, EVS, 1000G, UK10K internal databases); a 
frameshift mutation in FZD5 (c.656delCinsAG; p.Ala219Glufs*49, hereafter referred 
A219Xfs*49). This variant was then shown to co-segregate with the disease in all affected 
individuals available for testing with one exception, IV:7 (Fig. 1A). IV:7 has bilateral 
coloboma but is “married-in” to the family being unrelated to the affected individuals VI:2, V:1, 
IV:1, IV:4 and IV:6 (his wife). He has no prior family history of eye malformations and no 
other plausible causative variants could be identified in his exome sequence data. Two 
unaffected individuals (III:2 & V:8) also carried the mutation and were considered as non-
penetrant. Targeted re-sequencing of FZD5 in an additional 380 unrelated coloboma 
patients from the MRC Human Genetics Unit Cohort as part of UK10K revealed no other 
potentially pathogenic variants. 
Concurrently, FZD5 was screened as a candidate gene, based on mouse studies (27, 
32), in 172 unrelated individuals with coloboma from cohorts at National Eye Institute (NEI), 
USA and University of Alberta (U of A), Canada. These studies revealed the identical 
A219Xfs*49 mutation in all four affected individuals from family 111, where each exhibited 
bilateral coloboma and related phenotypes [e.g., microphthalmia, and cataract] (Fig. 1A, B).  
Haplotype analysis using five microsatellite markers flanking the FZD5 gene 
suggested a recent common ancestry between Family 3483 and Family 111 (Supplementary 
Fig. 2). Based on the information provided by family 3483 that individual II:4 had emigrated 
to North America, this female represented a plausible genetic link with Family 111. In 
addition, both families are of Mennonite ancestry and originated from the same region in 
Europe. For the purpose of calculating the two-point LOD score, we designated II:4 in Family 
3483 as the maternal great-grandmother of individual I:2 in Family 111, which is the closest 
possible link based on information from Family 111. This was a conservative approach, as it 
would generate a minimum possible LOD score associated with co-segregation of the 
disease and the mutation in the combined family. The linkage analysis was performed using 
the R package paramlink. Co-segregation of the FZD5 mutation with coloboma in the 
extended pedigree gave a two-point LOD score =0) ranging from 3.9-4.2 using penetrance 
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values between 0.1-1. It was not possible to obtain an accurate estimate of the penetrance 
for this mutation as we were not able to examine or genotype all apparently unaffected 
individuals in both branches of the family. However, on the basis of the genotypes we can 
safely conclude a relatively high but incomplete penetrance of the disease mutation.  
FZD5 has a single coding exon with a 5’ non-coding exon. As such the A219Xfs*49 
mutant transcript is not predicted to be a substrate for nonsense-mediated decay. The 
A219Xfs*49 mutation is thus likely to result in production of a truncated FZD5 protein with an 
intact highly conserved ligand-binding domain (extracellular cysteine rich domain, CRD) but 
lacking the seven transmembrane domains (Fig. 1D) (Supplementary Fig. 3). 
 Within the NEI and U of A cohorts, one additional rare missense variant was 
identified (c. 290A>T; p.Asp97Val (D97V); Supplementary table 1, Supplementary Fig. 4A, 
B). This variant is of uncertain significance as this variant was not present in the unaffected 
mother or brother and the father was deceased (Supplementary Fig. 4A). This mutation did 
not significantly change FZD5 protein level or its membrane localization by in vitro 
transfection assay (Supplementary Fig. 4C). Atomic non-local environment assessment 
(ANOLEA) predicted that the D97V variant would perturb local interactions (Supplementary 
Fig. 4D). Super Topflash (STF) reporter assays indicated a slight but consistent increase of 
Wnt9b-stimulated canonical Wnt activity by D97V mutation (Supplementary Fig. 4E) 
suggesting a gain-of-function.  
 
Altered expression of FZD5 A219Xfs*49 in zebrafish results in microphthalmia and 
coloboma 
To elucidate the functional relevance of the human FZD5 A219Xfs*49 mutation, zebrafish 
were used as a model system. Concordant with observations in mouse Fzd5 mutants (27, 
32), zebrafish fzd5 morphants exhibited coloboma and microphthalmia phenotypes (Fig. 2A-
D). In addition, over-expression of the FZD5-A219Xfs*49 mutant in zebrafish embryos also 
resulted in coloboma and microphthalmia (Fig. 2E-J). Surprisingly, these phenotypes were 
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more prevalent when the wild type FZD5 protein was over-expressed (Fig. 2K-L). We noted 
that the eye size was similar when either WT or FZD5-A219Xfs*49 mutant was over-
expressed (Supplementary Fig. 5). These observations suggest that precise FZD5 and/or 
Wnt signaling dosage is critical for ocular development.  
 
FZD5 A219Xfs*49 is a secreted protein that binds to Wnt but is incapable of mediating 
Wnt signaling 
To further understand the functional consequences of the human FZD5 A219Xfs*49 
mutation, we examined mutant protein expression and localization in vitro. Transfection of 
A219Xfs*49 cDNA construct into HEK293 cells produced a truncated FZD5 protein as 
predicted, containing the entire ligand-binding domain but not the transmembrane domains.  
Under non-reducing conditions, the mutant FZD5 A219Xfs*49 protein shows multiple bands 
in the cell extracts, including one of ~50 KD and several ~21 KD (Fig. 3A). With the addition 
of mercaptoethanol, the truncated FZD5 protein primarily migrated at a lower molecular 
weight in the ECM fraction (Fig. 3A). Live cell surface immunofluorescence analysis 
confirmed that truncated FZD5 did not localize to the outer cell membrane (in contrast to the 
full length FZD5) and instead displayed punctate and/or irregular extracellular staining (Fig. 
3B, Supplementary Fig. 6). As predicted, the A219Xfs*49 truncated FZD5 protein abrogated 
the ability to mediate both canonical (Fig. 3C, integrated TCF-dependent reporter) and non-
canonical WNT signaling activities (Fig. 3D, pulldown assay of Wnt5a stimulated GTP-RhoA). 
An engineered secreted FZD5-CRD protein (sCRD, fused with human Ig-Fc fragment) had 
an effect similar to the A219Xfs*49 FZD5 mutant (Fig. 3C, D), suggesting that the secretion 
of the latter is critical for its abnormal function. To examine whether A219Xfs*49 FZD5 binds 
to Wnt, co-IP experiments were conducted using cell extracts transfected with Wnt3a-myc, 
WNT7A-HA, FZD5 and FZD5 A219Xfs*49 constructs in different combinations (34, 35). We 
detected binding of FZD5 A219Xfs*49 to WNT7A as well as FZD5 (Supplementary Fig. 7), 
suggesting that a competition may exist between A219Xfs*49 FZD5 mutant and wild type for 
WNT utilization. 
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FZD5 A219Xfs*49 antagonizes both canonical and non-canonical Wnt signaling 
Given the abnormal function of truncated FZD5 A219Xfs*49, as indicated by its aberrant 
localization at the plasma membrane, and that A219Xfs*49 was associated with a dominant 
mode of inheritance in Family 3483 and Family 111, we reasoned that FZD5 A219Xfs*49 
may act as a secreted Frizzled-related protein (36).  This acquired secretory function may 
act non-cell autonomously and antagonize WNT-FZD5 activity expressed from the wild type 
allele.  To test this hypothesis, a co-culture assay was developed in which constructs 
A219Xfs*49 and Wnt9b plus FZD5 were respectively transfected into HEK293 and STF cells 
containing a built-in TCF luciferase reporter. Measurement of luciferase activity 
(schematically illustrated in Fig. 4A, left panel) revealed dose-dependent, non-cell 
autonomous inhibition of FZD5-mediated canonical WNT activity with co-cultured 
A219Xfs*49 expressing cells (Fig. 4A, middle panel). Moreover, the inhibition was reversed 
in a dose-dependent manner by increasing FZD5 expression (Fig. 4A, right panel). Similar 
results were obtained in a Wnt5a/FZD5-induced RhoA activity assay (Fig. 4B-C), which is a 
measure of non-canonical WNT signaling. Taken together, these data suggest that the 
A219Xfs*49 mutant protein functions in a dominant, non-cell autonomous manner to repress 
FZD5 signaling. 
 
Forced expression of FZD5 A219Xfs*49 in mouse retina leads to apical junction 
defects similar to those observed in Fzd5/8 compound mutants 
Previous studies in mice demonstrated apical junction defects in the retinal pigment 
epithelium of Fzd5/Fzd8 compound mutant retina, and these were likely to contribute to or 
cause abnormal neurogenesis and coloboma (32). To examine whether the A219Xfs*49 
mutation can mimic a FZD5 dominant loss-of-function, we overexpressed the FZD5- 
A219Xfs*49 mutation in mouse retina and evaluated FZD5-related downstream molecular 
events. Mutant constructs were electroporated into E13.5 mouse retina together with a 
constitutive Ub-GFP expression vector, and the retina was analyzed after 72 hrs of culture in 
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vitro. Consistent with apical junction defects in Fzd5-/-;Fzd8+/- compound mutant mouse 
retina (32), the overexpression of the A219Xfs*49 mutant also caused apical junction defects 
in cultured retinal explants, as indicated by attenuated expression of atypical Protein Kinase 
C (aPKC) (Fig. 5 A-F) and RhoA (Fig. 5 G-L). Both FZD5 and aPKC are expressed in retinal 
progenitor cells (see Fig. 5 and refs. (27, 32)). Decreased expression of these proteins likely 
represents the loss of concentrated apical localization of markers, which would not be 
demonstrated by immunoblotting. Furthermore, both human and mouse FZD5 showed the 
same apical retinal localization (Fig. 5M-R), supporting the hypothesis that they may mediate 
similar molecular events during human and mouse retinal development. 
 
DISCUSSION 
In the present study, we have identified an ultra-rare frameshift mutation in FZD5 in a large 
extended family with non-syndromic coloboma segregating as an autosomal dominant 
disorder. The open reading frame of FZD5 is entirely within the second exon which makes it 
unlikely that transcript would be subject to nonsense mediated decay since there is no 
intron-exon boundary 3’ to the premature termination codon (37). The distinct location of the 
frameshift in the open reading frame suggests that the truncated protein would have an 
antagonistic effect on WNT signaling. This predicted effect was demonstrated in cultured 
cells, zebrafish retina and mouse retinal explants that establish FZD5 as a strong candidate 
for human eye malformation(s). 
FZD5 mutations with similar predicted dominant negative effect appear to be 
extremely rare in human populations. A total of 18 copy number variations (CNVs) 
encompassing FZD5 locus are listed in DECIPHER database. Three patients with CNVs 
have eye abnormalities including cataract (one duplication case) and iris and/or chorioretinal 
coloboma (two deletion cases). However, a simple phenotype-genotype correlation could not 
be inferred since the CNV regions are large and include many genes. Only two FZD5 “loss-
of-function” alleles, both frameshift, are documented in ExAC. One of these, p.E231Afs*8 is 
also predicted to generate a secreted WNT-ligand binding domain with no transmembrane 
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domain. No phenotype information is available for the single individual carrying this mutation 
in a heterozygous state. Given that non-penetrance has been observed in at least two 
members of the family presented above, it is possible that this individual is non-penetrant or 
has microphthalmia, a disorder characterized by reduced ocular size that is closely 
associated with coloboma. An explanation for the rarity of such mutations may be related to 
the observation that Fzd5 null mouse embryos die before E11 due to placental angiogenesis 
defects (38). The non-penetrance of such variants may reflect rescue via genetic 
background effects and/or compensation by paralogs. The latter effect is prominent in 
Fzd5/Fzd8 mutant mice (32) although no obvious FZD8 mutations compatible with a digenic 
effect were identified in WES in the individuals presented here. Notably, similar non-
penetrance has been observed in patients with autosomal dominant coloboma due to YAP1 
(12) and SHH (8) mutation.   
Our results demonstrate a direct role for WNT-FZD signaling in optic fissure closure 
during human eye development. The A219Xfs*49 mutation converts FZD5 from a 
membrane-bound WNT receptor to a secreted frizzled antagonist that, by competing with 
WNT ligands or dimerization with wild type FZD5 (on the cell surface), might impart 
dominant-negative characteristics on WNT signaling. As a result of the disrupted WNT 
signaling, retinal neuroblasts exhibit apical junction defects (Supplementary Fig. 8) (32), 
which could directly or indirectly impact proliferation, survival and maturation of progenitors 
(Supplementary Fig. 8), leading to microphthalmia and coloboma. The dominant-negative 
role of A219Xfs*49 mutant is also consistent with the absence of observable ocular defects 
in heterozygous Fzd5 null allelic mice.  
To date, ocular disorders attributable to mutations in WNT signaling are Norrie 
disease (16, 17), osteoporosis-pseudoglioma syndrome (18) and familial exudative 
vitreoretinopathy (16, 17, 19-21). Our study directly implicates perturbed WNT signaling in 
coloboma and microphthalmia and is consistent with conclusions from mouse models (23, 
27, 32, 33). FZD5 mediates both canonical and non-canonical Wnt signaling pathways in 
different organisms and tissues (22, 27, 30). However, it is likely that FZD5-mediated non-
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canonical WNT signaling is the predominant pathway in the developing mammalian retina, 
as only minimal activity from the canonical pathway has been reported in these cells (39). 
The retinal apical junction defects observed in Fzd5/Fzd8-knockout mice, and retinal 
explants expressing the FZD5 mutant protein are likely to be the consequence of 
interactions between the actin cytoskeleton and components of the apical junctional 
complexes induced by the loss of non-canonical Wnt activity. The identification of FZD5 as a 
human coloboma gene extends opportunities to elucidate disease mechanisms and 
treatment paradigms for ocular malformations. 
 
MATERIALS AND METHODS 
Animal experiments 
Animal Care and Use Committee of the National Eye Institute approved all procedures 
involving the use of mice. Fzd5 and Fzd8 compound mutants were created and maintained 
as described previously (32). 
All zebrafish experiments were consistent with Canadian Council of Animal Care 
guidelines and approved by the University of Alberta’s Animal Care and Use Committee 
(Protocol #427). Experiments utilized the wildtype AB zebrafish strain or Tg(TOP:dGFP)w25 
transgenic strain (40). All embryos were grown at 28.5°C and staged according to 
developmental hallmarks (41). 
 
Zebrafish morpholino and FZD5 mRNA injection experiments 
Morpholino oligonucleotides (MO; GeneTools) were appropriately diluted in Danieau’s 
solution, then heated to 65°C for 10 min and allowed to cool before injection into the 1-2 cell 
stage embryos. A previously described translation blocking MO targeting fzd5 
(GATGCTCGTCTGCAGGTTTCCTCAT) was injected at a dose of 1.2 pmol (22). 
Morphological phenotypes were recapitulated by injecting a minimally overlapping MO 
(TGCAGGTTTCCTCA-TACTGGAAAGC) (data not shown). Human FZD5 WT and 
A219Xfs*49 cDNA was amplified using pRK5 constructs as template (see below) using the 
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following primer sequences: F – CACAGGATCCACCATGGCTCGGCCTG), R – 
CACAGAATTCCCTGAACCAAGTGGAA. PCR products were cloned into pCR4-TOPO 
(Invitrogen) for sequencing confirmation and sub-cloned into pCS2+ for mRNA synthesis. 
Constructs were linearized with NsiI (New England Biolabs) and mRNA was generated using 
the SP6 mMessage mMachine kit (Ambion). mRNA was purified using YM-50 Microcon 
columns (Amicon, Millipore) and the concentration was determined through 
spectrophotometry. The mRNA was diluted with DEPC-treated water and injected at a dose 
of 200pg into 1-cell stage embryos. 
 
Whole mount in situ hybridization, immunofluorescence and live imaging 
Live zebrafish embryos were photographed using an Olympus stereoscope with a Qimaging 
micropublisher camera. Whole mount in situ hybridization was performed as previously 
described (42). RT-PCR was used to generate 800-1200bp templates for probe synthesis or 
sub-cloned into pCR4-TOPO (Invitrogen). Immunofluorescence was performed as previously 
described (26) using rabbit polyclonal specific for Laminin (1/100) (Sigma L9393). After 
either in situ hybridization or immunofluorescence, eyes were dissected off and flat mounted 
for imaging on Zeiss AxioImager Z1 compound microscope with Axiocam HR digital camera.  
 
Patients and DNA sequencing 
Individuals with microphthalmia, anophthalmia and/or coloboma (MAC) were subjected to 
exome sequencing and Sanger sequencing. Genomic DNA samples fromcoloboma 
probands were analyzed by the National Eye Institute clinical eye center, UK10K consortium, 
MRC Human Genetics Unit at the IGMM, University of Edinburgh, and the University of 
Alberta.  Informed consent was obtained from each participant, and study approval provided 
by the relevant ethics boards (NIH IRB; U of A Health Research Ethics Board (Reference # 
01227), UK Multiregional Ethics Committee (Reference # 06/MRE00/76)). Five affected 
individuals from family 3483 (UK10K) were subjected to whole exome sequencing, and 
Sanger sequencing was used to test for the FZD5 mutation in all other available members of 
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this branch of the family. Four affected individuals from family 111 (HREB) were Sanger 
sequenced for the FZD5 gene. Exome sequencing was performed as described (43) with 
BWA 0.5.9 used for alignment, Picard 1.43 for duplicate marking, GATK 1.0.5506 for 
realignment around indels and base quality scores recalibration, and GATK Unified 
Genotyper for variant calling. LOD score was calculated using paramlink package in R (44). 
The oligonucleotides used to PCR amplify FZD5 are listed in supplementary table 2. 
 
Immunoblotting, immunofluorescence staining, and immunohistochemistry 
For examining expression of FZD5 mutant constructs, plasmid DNA of each mutant (D97V 
or A219Xfs*49) or wild type FZD5 construct was transfected into HEK293T cells cultured in 
6-well dishes. A total of 2 g DNA was used for transfection for each well, and biological and 
technical triplicates were made for each transfection. Transfected ells were cultured for 36 hr, 
supplemented with serum reduced medium (Opti-MEM, life technologies, Cat. #31985), 
continually cultured for another 24 hr. Cell medium was collected and store at -800C. Total 
cell extracts were prepared by adding 2XSDS Laemmli buffer (BIO-RAD, cat. #161-0737) 
onto cells rinsed with PBS. To prepare extracellular matrix (ECM) proteins, cultured cells 
were washed with PBS and incubated in PBS containing 10mm EDTA at 37°C for 30-45 min 
to remove the cells. ECM proteins are retained on the dish and solubilized in Laemmli buffer. 
Immunoblotting was performed as described previously (32) using custom-made 
rabbit antibody against the N-terminus 143 residues (27-169 amino acids) of the mouse 
FZD5 protein. The signal intensities were quantified by NIH ImageJ from three 
representative Western blots, and analyzed by Microsoft Excel. To detect FZD5 and FZD5 
A219Xfs*49 cellular or extracellular localization, two g DNA was used for transfection in 
each well (6-well plate) carrying coated coverslips. Transfected cells were cultured in 
DMEM-F12 for 48 hr. Immunofluorescence staining was conducted using the same antibody 
for detection of mutated/variant FZD5 proteins. To avoid cytoplasmic staining, live cells were 
first incubated with anti-Fzd5 antibody in cultured medium at 40oC for 2 hr, washed with PBS, 
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and then post-fixed with PFA. After rinse with PBS, secondary antibody was added to further 
proceed with immunohistochemistry. Standard immunohistochemistry was performed on 
PFA-fixed frozen retinal sections with anti-Fzd5 antibody (1:500), anti-aPKC (1:500, cell 
signaling, Cat. # 9378) and anti-RhoA (Cytoskeleton, Cat. # ARH03). 
 
FZD5 gene mutagenesis and Wnt/beta-catenin pathway activation assay 
FZD5 cDNA was cloned into pRK5 expression vector with a CMV promoter and site-directed 
mutagenesis was performed to generate the FZD5 A219Xfs*49 frameshift mutation. For 
testing canonical Wnt signaling activity, DNA constructs were transfected into STF HEK 293 
cells with a 7XTCF promoter-driven firefly luciferase reporter stably integrated in the genome 
(27). As shown in Fig. 4A, fixed amount of Wnt9b and FZD5 were cotransfected together 
with pCAG-renilla luciferase plasmids (RL, used for internal expression control) into STF 
cells. Different amount of FZD5 A219Xfs*49 and sCRD plasmids were transfected into 
regular HEK293 cells, respectively. Twelve hours after transfection, both STF and HEK293 
cells were lifted off by trypsin-EDTA, and mixed at 1:1 ratio and seeded into new plate for 
another 36hr culture. Biological and technical triplicates were prepared for each transfection.  
Cell extracts were then prepared for Firefly luciferase and renilla luciferase assay using 
Dual-luciferase assay system (Promega, E1960). Luminicence was measured sequentially 
by Turner Biosystem Modulus microplate reader. Firefly luciferase activity was normalized 
against renilla luciferase, and p-value calculation was performed using Microsoft Excel 
software student t-test function. 
 
Active RhoA assay for Wnt5 a stimulation 
HEK293 cells were cultured to 80% confluence in DMEM:F12 in 6-well dishes, transfected 
with FZD5 WT, A219Xfs*49 and sCRD plasmids, cultured for 24 hrs, then serum starved for 
24 hrs. Wnt5a recombinant protein conditioned medium (Wnt5a CM, Roche, Cat: 645-WN-
010/CF) was applied for 30min at 250ng/ml. Cells were lysed and then subjected to active 
GTP-RhoA assays according to the manufacturer instructions (pulldown assay: 
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RhoA/Rac1/Cdc42 assay kit, Cytoskeleton Inc, cat. # Bk- 030; G-lisa assay: RhoA G-lisa kit, 
Cytoskeleton Inc, cat. # Bk-124). Signal intensity was acquired by NIH ImageJ from three 
representative immunoblots. Light absorbance/optic density of HRP colorimetric reaction 
was measured (SpectraMax M), and the data was analyzed in Microsoft Excel. 
 
Retinal electroporation and explants culture 
Mouse embryonic retinas were dissected in DMEM medium at E13.5 excluding lens and 
RPE. Retinae were subjected to electroporation with BTX ECM830 electroporator in embryo 
GPS chamber (SunIVF, EGPS-010) supplied with 250 ng/l DNA solution in1XPBS. The 
following parameters were set for electroporation: 21 volts for electric field strength; 5X 
current pulses (50 ms duration); 900ms intervals between pulses. Retinas were then 
cultured in DMEM:F12 (Invitrogen, Cat. 12660-012) for 72 hr, harvested in PBS and fix in 
4% PFA, and subjected to sectioning and immunohistochemistry (32).  
 
Co-immunoprecipitation (Co-IP) 
HEK293T cells were transfected with 1.5 g DNA in each well of a 6-well dishe. Myc-tagged 
Wnt3a, HA-tagged WNT7A were coexpressed, respectively, with FZD5 or FZD5A219X49. 
Cell extracts and Co-IP procedure were performed essentially as described (34). Antibodies 
used were mouse anti-HA (TransGene Biotech, HT301), rabbit anti-myc (Sigma, C3956), 
and rabbit anti-FZD5 (custom-made). Protein A agarose resin was purchased from 
TansGene Biotech (DP301). 
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LEGENDS TO FIGURES 
Figure 1. A FZD5 frameshift mutation identified in a family with autosomal dominant 
coloboma 
A, Six- and three-generation family pedigrees of Family 3483 and Family 111, respectively. 
The dotted line links these independently ascertained pedigrees carrying the same mutation 
on an identical haplotype. This link is plausible based on the history obtained from both 
Mennonite families, with the likely linking individual (Family 3483 II:4) having emigrated from 
Europe to North America. For Family 3483, ocular images from the affected individuals are 
shown adjacent to the cognate pedigree symbol. COL numbers indicate individuals whose 
exomes were sequenced. Otherwise, Sanger sequencing was used for segregation analysis, 
which reveals high (0.8) but incomplete penetrance, as indicated by two obligate carriers 
that are unaffected. The pedigree key is in the top left corner. B, Representative images 
showing eye malformations in affected individuals from Family 111. The LOD score for the 
combined pedigree is shown below the family tree. C, Chromatopherogram of the frameshift 
FZD5 mutation (c.656delCinsAG). D, Schematic of the human FZD5 gene with hg19 
coordinates on chromosome 2. This gene is transcribed in the antisense direction relative to 
the genomic coordinate numbering. The position of the cDNA mutation is indicated in the 
open reading frame (ORF), which is entirely contained in the second exon. Below are 
diagrammatic representations of the wild type and “mutant” FZD5 peptides. The WNT 
binding domain (dark blue box) is common to both, and the seven transmembrane domains 
(orange boxes) are present only in the wild type protein of 585 residues. The mutation 
results in the truncation at Ala219 (substituted to Glu) with an aberrant extension of 48 
residues (red box), resulting in a protein of 266 amino acids. 
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Figure 2. Morpholino knockdown and over-expression of FZD5 causes 
microphthalmia and coloboma in zebrafish. 
A-B, Representative images of live embryos at 3 dpf, either uninjected (A) or injected with 
1.2 pmol of fzd5 translation blocking morpholino (MO; B). C-D, In situ hybridization for GFP 
was performed at 28 hpf in Tg[TOP:dGFP] embryos to assess levels of canonical Wnt 
signaling in uninjected (C; n=26/26 eyes) or fzd5 morphants (D; n=23/25 eyes). Retinal GFP 
expression was increased in morphants, while lens expression was decreased (D compare 
to C), suggesting a tissue-specific function for fzd5 in Wnt signaling. E-L, Embryos were 
injected at the 1-cell stage with either 200 pg human WT FZD5 mRNA or A219Xfs*49 FZD5 
mRNA and imaged to analyze eye size and prevalence of coloboma. Injection of WT FZD5 
caused higher incidence of microphthalmia (K, ***, p<0.0002) and coloboma (L, **, p=0.016; 
*, p=0.008) compared to injection of A219Xfs*49 FZD5 mRNA. All images represent majority 
of observed phenotypes in each injection group. E-G, Live images of larvae at 3 dpf; H-J, 
eyes labeled with β-laminin antibody at 3 dpf. K-L, Quantification of ocular phenotypes seen 
in E-J. For E-L, Number of embryos analyzed for microphthalmia: uninjected (n=85), WT 
FZD5 (n=34), A219Xfs*49 (n=67), 2 experimental replicates. Number of embryos analyzed 
for coloboma: uninjected (n=54), WT FZD5 (n=20), A219Xfs*49 (n=54), 2 experimental 
replicates.  
 
 
Figure 3. FZD5-A219Xfs*49 is incapable of mediating Wnt signaling 
A, Immunoblot analysis of subcellular fractions from transfected HEK293 cells. FZD5 
A219Xfs*49mutant protein is detected primarily in extracellular matrix (ECM) fraction. 
Secreted Cysteine-rich domain (sCRD) is expressed in both culture medium (CM) and ECM. 
CE: cell extract. B, Live cell immunofluorescence detection. Immunofluorescence staining 
was conducted to detect FZD5 proteins expression in transfected cells on coated coverslips 
(see materials and methods). WT FZD5 is primarily present on the cell surface (left panel), 
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whilst majority of A219Xfs*49 mutant protein is detected extracellularly (middle panel), 
presumptively in ECM (doted staining). Negative control with vector transfection is shown in 
the right panel. C, Wnt9b-induced canonical Wnt signaling in SupertopFlash (STF) reporter 
cell line. Cells were transfected with 0.5ug Wnt9b plasmid combined with 0.25ug other 
plasmids. Like sCRD, FZD5 A219Xfs*49 mutant protein is not able to mediate Wnt9b-
induced canonical Wnt signaling. The rightmost bar represents Wnt9b-induced canonical 
Wnt activity by wild type FZD5, which is significantly different from all other froms of FZD5. D, 
Representative image foractive-Rho pulldown assays for non-canonical Wnt signaling. 
HEK293 cells were transfected with FZD5 WT, A219Xfs*49 and sCRD plasmids, treated 
with Wnt5a recombinant protein conditioned medium. Active GTP-RhoA assays strictly 
followed the manufacturer instructions (Cytoskeleton Inc, cat. # Bk-030) (details see 
materials and methods). Wnt5a-enhanced formation of GTP-RhoA is obtained in the 
presence of FZD5, but not A219Xfs*49 mutant or sCRD. The signal intensities were 
quantified by NIH ImageJ from three immunoblots for three independent experiments, and 
analyzed by Microsoft Excel (Student t-test, ***, p<0.001). 
 
Figure 4. Non-cell autonomous dominant-negative effect of FZD5 A219Xfs*49 mutant 
on Wnt signaling.  
A, Wnt9b-FZ5 signaling. All experiments were done in triplicates of at least three 
independent transfections. Left panel, illustration of the experimental scheme. A fixed 
amount of Wnt9b and FZD5 was co-transfected with pCAG-renilla luciferase plasmids (RL, 
used for internal expression control) into STF cells. Different amounts of FZD5 A219Xfs*49 
and sCRD plasmids were transfected into HEK293 cells. After 12 hr, both STF and HEK293 
cells were collected by trypsin-EDTA, mixed at 1:1 ratio, and seeded into a new plate for 
another 36 hr. Cell extracts were then prepared for Firefly luciferase and renilla luciferase 
assay. Middle Panel, inhibition of Wnt9b/FZD5 activity by either A219Xfs*49or sCRD in a 
dose-dependent manner. Firefly Luciferase activities were normalized against Renilla 
Luciferase, and statistics was performed using Microsoft Excel software. Right panel, the 
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inhibition of FZD5-mediated Wnt signaling by A219Xfs*49 or sCRD A219Xfs*49 or sCRD 
was reversed by augmenting FZD5 expression.  
B, Wnt5a-FZD5 signaling. RhoA G-lisa assay showed that Wnt5a/FZD5-stimulated 
accumulation of GTP-RhoA was abolished by A219Xfs*49 mutant or sCRD protein (compare 
the right three bars). Samples preparation was as described in Fig. 3D, G-lisa assay 
followed instructions of RhoA G-lisa kit (Cytoskeleton Inc). Absorbance of HRP colorimetric 
reaction was measured by SpectraMax M. The data were quantified by Microsoft Excel.  
C, Inhibition of RhoA activation by A219Xfs*49 or sCRD protein was reverted by increased 
FZD5 expression. Left panel: similar experimental scheme in ‘A’ was used for testing non-
cell autonomous effects of A219Xfs*49 on Wnt5a/FZD5 induced RhoA activation. Right 
panel: The inhibition of RhoA activation (G-lisa assay) was reverted by increased FZD5 
expression. ***, p<0.001, Student t-test. 
 
Figure 5. Overexpression of FZD5 A219Xfs*49 led to similar apical junction defects 
that were reported in mouse Fz5/8 compound mutants.  
Mouse embryonic (E13.5) retina was dissected and subjected to electroporation supplied 
with wild type FZD5 and FZD5 A219Xfs*49 DNA solution. The retinae were cultured for 72 
hr and harvested for immunohistochemistry. A-F, aPKC localization in vector (A), wild type 
FZD5 (WT) (B) and A219Xfs*49 mutant (C) electroporated retinae. Note the loss of apical 
localization of aPKC in A219Xfs*49-expressing retina (C). D-F, Images of A, B, and C 
merged with coelctroporated eGFP, respectively. G-I, Similar as aPKC, apical RhoA 
enrichment is also greatly attenuated (compared to G and H). J-L, Images of G, H, and I 
merged with co-elctroporated eGFP, respectively. M-R, Localization of FZD5 protein in 
mouse and human retina. M, Apical localization of FZD5 protein in wild type mouse retina 
(above dashed bracket). N, Same protein localization of FZD5 was detected in human retina. 
O, Mouse Fzd5 conditional mutant retina showed absence of apical FZD5 protein. P-R, 
Images from M-O merged with DAPI, respectively. 
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II:1 II:2-4 II:5 II:6 II:7
III:1
a. b.
c. d.
3
3’UTR ORF
5’UTR
exon 2 exon 1
1 219 FZD5 p.Ala219Glufs*49
WNT binding
domain
c.656delCinsAG
266
transmembrane domains
frameshift sequence
208628000 208630000 208632000 208634000
Family 111
27
29 31
28
30
32
Maximum LOD for combined family is 4.07 at θ = 0 penetrance = 0.8 
1-32 Number in linkage table
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